FLAVONOIDS AS DNA TOPOISOMERASE ANTAGONISTS AND POISONS - STRUCTURE-ACTIVITY-RELATIONSHIPS

被引:243
作者
CONSTANTINOU, A
MEHTA, R
RUNYAN, C
RAO, K
VAUGHAN, A
MOON, R
机构
[1] IIT,RES INST,DIV LIFE SCI,CHICAGO,IL 60616
[2] LOYOLA UNIV,DEPT RADIOTHERAPY,MAYWOOD,IL 60153
来源
JOURNAL OF NATURAL PRODUCTS-LLOYDIA | 1995年 / 58卷 / 02期
关键词
D O I
10.1021/np50116a009
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Selected flavonoids were tested for their ability to inhibit the catalytic activity of DNA topoisomerase (topo) I and II. Myricetin, quercetin, fisetin, and morin were found to inhibit both enzymes, while phloretin, kaempferol, and 4',6,7-trihydroxyisoflavone inhibited topo II without inhibiting topo I. Flavonoids demonstrating potent rope I and II inhibition required hydroxyl group substitution at the C-3, C-7, C-3', and C-4' positions and also required a keto group at C-4. Additional B-ring hydroxylation enhanced flavonoid cope I inhibitory action. A C-2,C-3 double bond was also required, but when the A ring is opened, the requirement for the double bond was eliminated. Genistein has been previously reported to stabilize the covalent topo II-DNA cleavage complex and thus function as a topo II poison. All flavonoids were tested for their ability to stabilize the cleavage complex between topo I or topo II and DNA. None of the agents stabilized the topo I-DNA cleavage complex, bur prunetin, quercetin, kaempferol, and apigenin stabilized the topo II DNA-complex. Competition experiments have shown that genistein-induced topo II-mediated DNA cleavage can be inhibited by myricetin, suggesting that both types of inhibitors (antagonists and poisons) interact with the same functional domain of their target enzyme. These results are of use for the selection of flavonoids that can inhibit specific topoisomerases at specific stages of the topoisomerization reaction.
引用
收藏
页码:217 / 225
页数:9
相关论文
共 32 条
[1]  
ADLAKHA RC, 1989, CANCER RES, V49, P2052
[2]   SITE-SPECIFIC DNA CLEAVAGE BY MAMMALIAN DNA TOPOISOMERASE-II INDUCED BY NOVEL FLAVONE AND CATECHIN DERIVATIVES [J].
AUSTIN, CA ;
PATEL, S ;
ONO, K ;
NAKANE, H ;
FISHER, LM .
BIOCHEMICAL JOURNAL, 1992, 282 :883-889
[3]  
BODLEY AL, 1987, NATL CANCER I MONOGR, V4, P31
[4]   INHIBITION OF TYPE-II TOPOISOMERASE BY FOSTRIECIN [J].
BORITZKI, TJ ;
WOLFARD, TS ;
BESSERER, JA ;
JACKSON, RC ;
FRY, DW .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (21) :4063-4068
[5]  
CONSTANTINOU A, 1989, CANCER RES, V49, P1110
[6]  
CONSTANTINOU A, 1990, CANCER RES, V50, P2618
[7]   THE EFFECT OF TOPOISOMERASE INHIBITORS ON THE EXPRESSION OF DIFFERENTIATION MARKERS AND CELL-CYCLE PROGRESSION IN HUMAN K-562 LEUKEMIA-CELLS [J].
CONSTANTINOU, A ;
GRDINA, D ;
KIGUCHI, K ;
HUBERMAN, E .
EXPERIMENTAL CELL RESEARCH, 1992, 203 (01) :100-106
[8]   MECHANISM OF ACTION OF INHIBITORS OF DNA-SYNTHESIS [J].
COZZARELLI, NR .
ANNUAL REVIEW OF BIOCHEMISTRY, 1977, 46 :641-668
[9]  
DRAKE FH, 1989, CANCER RES, V49, P2578
[10]   PROTEIN-KINASE C INHIBITION BY PLANT FLAVONOIDS - KINETIC MECHANISMS AND STRUCTURE-ACTIVITY-RELATIONSHIPS [J].
FERRIOLA, PC ;
CODY, V ;
MIDDLETON, E .
BIOCHEMICAL PHARMACOLOGY, 1989, 38 (10) :1617-1624